The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Viking Therapeutics Inc shares valued at $8,313,601 were sold by Lian Brian on Jan 06 ’25. At $42.75 per share, Lian Brian sold 194,490 shares. The insider’s holdings dropped to 2,366,570 shares worth approximately $66.12 million following the completion of this transaction.
Also, Mancini Marianna sold 54,215 shares, netting a total of over 2,317,599 in proceeds. Following the sale of shares at $42.75 each, the insider now holds 374,134 shares.
Before that, ZANTE GREG had sold 50,309 shares from its account. In a trade valued at $2,150,595, the Chief Financial Officer traded Viking Therapeutics Inc shares for $42.75 each. Upon closing the transaction, the insider’s holdings decreased to 50,309 shares, worth approximately $4.62 million.
As published in their initiating research note from Scotiabank on February 13, 2025, Viking Therapeutics Inc [VKTX] has been a Sector outperform and the price target has been revised to $102. Analysts at Citigroup started covering the stock with ‘”a Neutral”‘ outlook in a report released in early February. As of December 02, 2024, Piper Sandler has initiated its “an Overweight” rating for VKTX. Earlier on November 22, 2024, B. Riley Securities initiated its rating. Their recommendation was “a Buy” for VKTX stock.
Analyzing VKTX Stock Performance
During the last five days, there has been a surge of approximately 0.43%. Over the course of the year, Viking Therapeutics Inc shares have dropped approximately -30.57%. Shares of the company reached a 52-week high of $43.55 on 01/06/25 and a 52-week low of $24.41 on 03/04/25. A 50-day SMA is recorded $34.40, while a 200-day SMA reached $52.56.
Support And Resistance Levels for Viking Therapeutics Inc (VKTX)
According to the 24-hour chart, there is a support level at 27.17, which, if violated, would cause prices to drop to 26.41. In the upper region, resistance lies at 28.50. The next price resistance is at 29.07. RSI (Relative Strength Index) is 41.26 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.17, which suggests the price will decrease in the coming days. Percent R is at 70.52%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Which companies own the most shares of Viking Therapeutics Inc (VKTX)?
On November 04, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and reiterated coverage with a $102.
